Products

Segasist P-AC

Segasist P-AC

Related Content

Study: Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps in U.S.
News | Radiation Oncology
Study: Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps in U.S.

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
GE HealthCare, Mayo Clinic Collaborate to Advance Personalized Cancer Treatment
News | Radiation Oncology
GE HealthCare, Mayo Clinic Collaborate to Advance Personalized Cancer Treatment

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy ...

Time July 09, 2026
arrow
Artera to Address MMAI Risk Stratification,Treatment Decisions in Cancer
News
Artera to Address MMAI Risk Stratification,Treatment Decisions in Cancer

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer
News | FDA
FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study
Feature
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring ...

Time July 01, 2025
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi
News | Radiation Therapy
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
Avenda Health’s study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and accurate diagnostic tool
News | Artificial Intelligence
New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators
News | Oncology Information Management Systems (OIMS)
RayCare 2024A Interoperable with Varian TrueBeam

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now